(4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione

C20H26O5 — CID 162920199

IUPAC(4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione
SMILESC=C(C)[C@@H]1CCC2=C[C@H](C[C@@](C)(O)CC(=O)/C=C(/C)C(=O)C1)OC2=O
InChIInChI=1S/C20H26O5/c1-12(2)14-5-6-15-8-17(25-19(15)23)11-20(4,24)10-16(21)7-13(3)18(22)9-14/h7-8,14,17,24H,1,5-6,9-11H2,2-4H3/b13-7-/t14-,17-,20+/m1/s1
InChIKeyKTZVYYUYMCPVAV-ZNRNYIKGSA-N
MW346.42 g/mol
LogP2.83
Rot. Bonds1

About (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione

(4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione (PubChem CID 162920199) has the molecular formula C20H26O5 and a molecular weight of 346.42 g/mol. Its IUPAC name is (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione.

Molecular Properties

Compound Name(4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione
PubChem CID162920199
Molecular FormulaC20H26O5
Molecular Weight346.42 g/mol
Exact Mass346.18
IUPAC Name(4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione
SMILESC=C(C)[C@@H]1CCC2=C[C@H](C[C@@](C)(O)CC(=O)/C=C(/C)C(=O)C1)OC2=O
InChIInChI=1S/C20H26O5/c1-12(2)14-5-6-15-8-17(25-19(15)23)11-20(4,24)10-16(21)7-13(3)18(22)9-14/h7-8,14,17,24H,1,5-6,9-11H2,2-4H3/b13-7-/t14-,17-,20+/m1/s1
InChIKeyKTZVYYUYMCPVAV-ZNRNYIKGSA-N
XLogP2.83
TPSA80.67 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds1
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500346.42
LogP ≤ 52.83
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione?
The IUPAC name of (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione (CID 162920199) is (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione.
What is the SMILES notation for (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione?
The canonical SMILES for (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione is C=C(C)[C@@H]1CCC2=C[C@H](C[C@@](C)(O)CC(=O)/C=C(/C)C(=O)C1)OC2=O.
What is the InChIKey of (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione?
The InChIKey is KTZVYYUYMCPVAV-ZNRNYIKGSA-N. The full InChI is InChI=1S/C20H26O5/c1-12(2)14-5-6-15-8-17(25-19(15)23)11-20(4,24)10-16(21)7-13(3)18(22)9-14/h7-8,14,17,24H,1,5-6,9-11H2,2-4H3/b13-7-/t14-,17-,20+/m1/s1.
What are the key properties of (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione?
(4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione has a molecular weight of 346.42 g/mol, XLogP of 2.83, 1 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (4R,7Z,11R,13S)-11-hydroxy-7,11-dimethyl-4-prop-1-en-2-yl-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione is sourced from PubChem (CID 162920199), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).